We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Healing clouds is an online platform that connects holistic health practitions with various modalities such as reiki, theta healing, pranic healing and many more. They offer holistic healing globally through live and secure video sessions. EIS (pending) SEIS (pending)
days to go: Expired investment: £122,080
Loupe London is a jewellery company that aims to join London’s £42 billion-a-year creative industries market and set a new benchmark into the art of jewellery making. It plans to create an experiential destination in the heart of London’s heritage-rich 'Jewellery Quarter', and connect UK artisans and discerning consumers who share an appreciation for craft, creativity, and unique design. Loupe's team strives to celebrate UK's famous 'Hatton Garden' heritage, protect artisan skills by offering business support, and establish a workspace for artisans and future talent to build their careers. The company estimates that 80% of consumers prefer independent brands, are mindful of sustainable purchases and attracted to 'Made in UK' products. Loupe aims to target this cater to this segment. The company will use the investment to build creative utilitarian immersive space and a website with integrated social channels.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £77,738
Fighter Shots (FS) is a company that makes daily energy shots from a range of sources like ginger, turmeric and manuka honey to boost and strengthen human immunity. FS has sold over 50,000 bottles since its launch in November 2019. The functional drinks market has the potential to grow by $180 billion (11% CAGR) to $270 billion from 2020-24 on the back of COVID-19. FS aims to be a disruptor in this segment and asserts that its a dependable substitute to coffee and sugary drinks. It has secured listings with the Health Store, Tree of Life and DDC. The company is also developing sales in the United Arab Emirates (UAE). FS will use the investment to build its digital marketing and sales capabilities to bring its product to more customers.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
PANTSANDSOCKS.COM is an online retailer and subscription service that helps men buy branded underwear and socks. They state their mission is to be a convenient, one-stop-shop for top brands in the market. PANTSANDSOCKS.COM argues that it is an ‘Authorised Stockist’ of 16+ leading brands including Calvin Klein, Hugo Boss, Polo Ralph Lauren and Tommy Hilfiger. The company claims to have fulfilled over 2,000 orders, welcomed over 100,000 unique website visitors to its site, achieved a 4.6/5, ‘Excellent’ Trustpilot rating, and signed up over 4,000 people to its database. The company has integrated with Amazon and Google Shopping to provide additional revenue streams. They state they will use the investment to achieve 100,000 unique visitors per month by the end of Q3 2021, meet its business targets, and continue to develop its internal capabilities at a sustainable rate.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £205,504
Perfino designs natural scent infused artisan jewellery. The company argues that one-third of humans are intolerant to synthetic chemicals and that up to 60% of these chemicals may be absorbed into the bloodstream. Perfino wants to change this scenario and provide fragrance lovers access to natural scents with no skin contact. Perfino pendants come with six super-absorbent lava stones and a bottle of expertly blended natural essential oils. Users need to simply add a drop to a stone, put it in the pendant, and enjoy a wonderful scent all day long. The company aims to disrupt the $310 billion global jewellery/perfume market with its products. Perfino's CEO has featured in the BBC’s CEO Secrets and Radio 4 Business Matters. The company will use the investment to grow its team and product range, boost sales and set up a membership service.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £74,268
Cheerfy allows businesses to exceed the expectations of every customer by knowing who they are and what they want the second they walk in the door. By using WiFi, hotels for example can get notifcations when VIP members arrive so they can speed up the check in process. 
days to go: Expired investment: £207,430
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph